Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
Finest Research at Rabin Medical Center
Rabin Medical Center, affiliated with the Tel Aviv University Sackler School of Medicine, is one of the largest and most distinguished academic medical institutions in Israel.
A Leader in Global Oncology: Rabin Medical Center’s Davidoff Cancer Center
Davidoff Cancer Center is an international leader in cancer care and has set the standard as Israel’s first and preeminent comprehensive cancer center.
Laron's Syndrome A Rare Genetic Syndrome Causing Dwarfism: Professor Laron Receives The 2009 Israel Prize For Medical Research
Professor Zvi Laron has been awarded The 2009 Israel Prize for Medical Research, the country's highest honor, for his groundbreaking research on growth hormone activity.